Document Detail

Liposomal amphotericin B (AmBisome) reduces dissemination of infection as compared with amphotericin B deoxycholate (Fungizone) in a rate model of pulmonary aspergillosis.
MedLine Citation:
PMID:  8877535     Owner:  NLM     Status:  MEDLINE    
The efficacy of AmBisome, a liposomal formulation of amphotericin B, was compared with that of Fungizone (amphotericin B desoxycholate), in a rat model of unilateral, pulmonary aspergillosis. Repeated administration of cyclophosphamide resulted in persistent, severe granulocytopenia. The left lung was inoculated with a conidial suspension of Aspergillus fumigatus, thus establishing an unilateral infection. Antifungal treatment was started 40 h after fungal inoculation, at which time mycelial disease was confirmed by histological examination. Both Fungizone 1 mg/kg and AmBisome 10 mg/kg resulted in increased survival in terms of delayed as well as reduced mortality. Quantitative cultures of lung tissue showed that only AmBisome 10 mg/kg resulted in reduction of the number of fungal cfus in the inoculated left lung. Compared with Fungizone, both AmBisome 1 mg/kg/day and AmBisome 10 mg/kg/day significantly prevented dissemination from the infected left lung to the right lung. In addition, both AmBisome regimens reduced hepatosplenic dissemination, and the 10 m/kg dosage fully prevented this complication. In conclusion, when compared with Fungizone, in this model AmBisome is more effective in reducing dissemination of unilateral, pulmonary aspergillosis, even when given in relatively low dosage. Such low dosages may have a place in prophylactic settings.
A C Leenders; S de Marie; M T ten Kate; I A Bakker-Woudenberg; H A Verbrugh
Related Documents :
8589135 - Limited toxicity of prolonged therapy with high doses of amphotericin b lipid complex.
791105 - Can mannitol reduce amphotericin b nephrotoxicity? double-blind study and description o...
3027845 - Itraconazole: pharmacologic studies in animals and humans.
9776995 - Efficacy of oral administration of itraconazole to cats with dermatophytosis caused by ...
1680625 - The disposition and metabolism of [14c]piritrexim in rats after intravenous and oral ad...
11460755 - Interactive effects of cadmium and benzo[a]pyrene on metallothionein induction in mummi...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  The Journal of antimicrobial chemotherapy     Volume:  38     ISSN:  0305-7453     ISO Abbreviation:  J. Antimicrob. Chemother.     Publication Date:  1996 Aug 
Date Detail:
Created Date:  1997-01-14     Completed Date:  1997-01-14     Revised Date:  2009-11-03    
Medline Journal Info:
Nlm Unique ID:  7513617     Medline TA:  J Antimicrob Chemother     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  215-25     Citation Subset:  IM    
Department of Bacteriology, University Hospital Rotterdam-Dijkzigt, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Agranulocytosis / chemically induced
Amphotericin B / administration & dosage,  therapeutic use*
Antifungal Agents / therapeutic use*
Aspergillosis / drug therapy*
Aspergillus fumigatus / drug effects
Deoxycholic Acid / therapeutic use*
Disease Models, Animal
Drug Combinations
Lung Diseases, Fungal / drug therapy*
Reg. No./Substance:
0/Antifungal Agents; 0/Drug Combinations; 0/Liposomes; 1397-89-3/Amphotericin B; 83-44-3/Deoxycholic Acid; 87687-70-5/amphotericin B, deoxycholate drug combination

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  CAT III chloramphenicol resistance in Pasteurella haemolytica and Pasteurella multocida isolated fro...
Next Document:  Correlation of in-vitro activity and pharmacokinetic parameters with in-vivo effect of amoxycillin, ...